Eukaryotic cells sense and move towards a chemoattractant gradient, a cellular process referred as chemotaxis. Chemotaxis plays critical roles in many physiological processes, such as embryogenesis, neuron patterning, metastasis of cancer cells, recruitment of neutrophils to sites of inflammation, and the development of the model organism Dictyostelium discoideum. Eukaryotic cells sense chemo-attractants using G proteincoupled receptors. Visual chemotaxis assays are essential for a better understanding of how eukaryotic cells control chemoattractant-mediated directional cell migration. Here, we describe detailed methods for: 1) real-time, high-resolution monitoring of multiple chemotaxis assays, and 2) simultaneously visualizing the chemoattractant gradient and the spatiotemporal dynamics of signaling events in neutrophil-like HL60 cells.
Introduction
Eukaryotic cells sense and move toward the higher concentration within a chemoattractant gradient, a cellular process referred as chemotaxis. Chemotaxis plays critical roles in many physiological processes, such as embryogenesis 1 , neuron patterning 2 , metastasis of cancer cells 3 , recruitment of neutrophils to sites of inflammation 4 , and the development of the model organism Dictyostelium discoideum 5 . In general, eukaryotic cells sense chemoattractants using G protein-coupled receptors 5 . The engagement of chemoattractants with these receptors promotes dissociation of the heterotrimeric G proteins Gα and Gβγ, which in turn activate downstream signal transduction pathways that ultimately regulate the spatiotemporal organization of the actin cytoskeleton to drive cell migration [5] [6] [7] [8] [9] .
Cell biologists have been developing and improving chemotaxis assays to examine how G protein-coupled receptor (GPCR) signaling mediates directed cell migration. The Boyden chamber or transwell migration assay was developed in 1960 by Boyden 10 . The assay works by creating a gradient of chemoattractant compounds between two wells that are separated by a microporous membrane. Its simplicity and ease of use make it the most widely used chemotaxis assay to date. However, the assay does not enable the migrating process of the cells to be visualized. The Zigmond chamber is the first visual microfluidic device that allows clear imaging of cell migration on a coverslip across a narrow constriction toward a source chemoattractant 8. After assembling the holder, place the bottom of the holder on the light box to confirm that there are no air bubbles in the wells. If air bubbles are detected, remove them using the provided plastic syringe fitted with a sample loading tip. 9. Remove the cover and put the assembly onto the plate on top of the cell mobility analysis device unit. Attach the sensor block to the holder.
6. Prepare HL60 Cells for Chemotaxis Assay: 1. Calculate the cell density of the differentiated HL60 cells with a hemocytometer. After 5 days of differentiation, the cell density is around 1.0 x 10 6 cells/ml.
2. Calculate the final volume of HL60 cells at a final cell density of 2 x 10 6 cells/ml. For example, if the cell density of the differentiated HL60 cells is 1.0 x 10 6 cells/ml, then 10 ml of differentiated HL60 cells will be resuspended with 5 ml of 0.1% BSA/RPMI 1640 medium to reach 2 x 10 6 cells/ml.
3. Centrifuge differentiated HL60 cells at 200 x g for 5 min at RT. Remove the supernatant and resuspend the cells with the calculated volume of 0.1% BSA/RPMI 1640 medium at step 3.6.2) to a final cell density of 2 x 10 6 cells/ml.
7. Start up the cell mobility analysis device unit and PC for image acquisition. Connect the unit to the PC. Turn on the cell mobility analysis device. Turn on the PC. 8. Start Up the Cell Mobility Analysis Device Software.
1. Observe 5 control panels: camera, heater, shooting, memo, and camera images. 2. On the camera image control panel, use "Horizontal line" or "Vertical line" to adjust the holder/view position in real time to center the camera in the camera image panel. 3. On the camera control panel, select CH1 to CH6 to move the camera to the defined channel. To center the view fields of a channel, click "Move L" or "Move R" to adjust the X-coordinate of the camera and center the camera's position horizontally. 4. Adjust the Y-coordinate of the camera by turning the position knob on the front panel of the cell mobility analysis device unit to vertically adjust the image to center the screen. 5. On the heater control panel, set the "holder temp" to 37.0 °C and the "plate temp" to 39 °C. Click "Heat" to start heating. Also click "holder" to control the temperature using the thermal sensor connected to the holder. 6. On the shooting panel, enter "15 sec" at "Interval" and "30 min" at "Time" for the intervals and the duration of the chemotaxis assay.
Check "Heater off at the end of shooting" for safety reasons. Designate a destination for the stored images. 7. On the memo panel, input the specifics of the experiments, such as cell line used, whether or not treatment was applied, and the concentration of chemo-attractants applied. 8. Confirm the center position of all of the channels that will be used in the experiments, and repeat the adjustment for all channels if needed.
9. Inject and Align Cells as Follows: 1. Remove the buffer from the holder, and take out 8 μl of buffer from the third well from the top for each channel. 
Transfection with Electroporation
1. Differentiate HL60 cells 5 days before the experiment as described in Section 1. Coat 4-well or 1-well chambers as instructed in Section 2. 2. Prepare and warm RPMI 1640 electroporation recovery medium, which contains RPMI 1640 medium, 20% (v/v) FBS, 0.1 mM sodium pyruvate, and 25 mM HEPES, to 37 °C. 3. Right before starting the transfection experiment, add either 300 μl or 3 ml RPMI 1640 culture medium into the wells of the pre-coated 4-well or 1-well chambers, respectively. 4. Incubate the chambers in a humidified 37 °C incubator with 5 % CO 2 . Use these chambers immediately or store in the incubator for future use (two weeks). 5. Count the cell density of the differentiated HL60 cells with a hemocytometer.
NOTE: The cell density often reaches about 1.0 x 10 6 cells/ml. Cell density greater than 3.0 x 10 6 cells/ml usually gives undesirable transfection efficiency. As HL60 cells are suspension cells, no resuspension is required. 6. Centrifuge the cells at 200 x g for 5 min at RT. Remove the supernatant and resuspend 2 x 10 6 HL60 cells in 100 μl of transfection reagent.
7. Add 4 μg of GFP-PKD1 plasmid 9 into the 100 μl mixture of cells and transfection reagents and mix gently and thoroughly. Add the mixture into the cuvette provided. 8. Select the manufacturer's pre-set program for the human leukocyte cell line and perform the electroporation.
NOTE: Further information is available from the manufacturer's website. 9. After electroporation, immediately and gently add pre-warmed 500 μl RPMI 6140 electroporation recovery medium to the cells, and gently transfer the cells from the cuvette to a 1.6ml tube with the plastic pipettes provided. 10. Incubate the cells for 30 min in a humidified 37 °C incubator with 5% CO 2 . Seed 100 μl or 500 μl of cells into one well of a 4-well or a 1-well chamber, respectively. 11. Add RPMI 1640 culture medium to a final volume of 1 ml or 4 ml to that same well of a 4-well or a 1-well chamber, respectively. Incubate the cells in a humidified 37 °C incubator with 5 % CO 2 for 3 hr. Pre-warm RPMI 1640 starving medium to 37 °C. 12. Using a 1ml pipette, gently remove 0.8 ml or 3 ml of RPMI 1640 culture medium from the well of a 4-well chamber or a 1-well chamber, respectively. Be gentle and avoid sucking away adhering HL60 cells. NOTE: HL60 cells grow and are differentiated in suspension media. After being differentiated or with certain treatments, HL60 cells adhere to the substratum coated with polylysine, collagen, gelatin, or fibronectin. 13. Add 0.8 ml or 3 ml of RPMI 1640 starving medium into the well of a 4-well or 1-well chamber, respectively. Wait 1 hr.
Representative Results
Simultaneous imaging of chemotaxis of multiple HL60 cells using cell mobility analysis device Based on the principle of microfluidics 16 , the manufacturer has provided simulated profiles of gradients: a gradient is generated within 1 min, stabilized within 5 min, and maintained over 2 hr. The highly predictable profiles of the stable gradients generated by microfluidics allow multiple chemotaxis assays to be carried out simultaneously. In the present study, we observed three simultaneous chemotaxis assays (Figure 2A and Movie 1). We found that HL60 cells started chemotaxing immediately after the chemoattractant was injected into the well of the chemoattractant, and kept chemotaxing in a straight path for the following 60 min, consistent with the simulation results for gradient stability. Tracing the travel path and morphology of the cells allows quantitative measurements and subsequent comparison of the chemotaxis behaviors using a chemotaxis index that includes total path length, speed, directionality, and roundness of the cells (Figure 2B) . Total path length is the sum of the lengths of the line segments connecting the centroids of the path. Speed is obtained by dividing the total path length by the time. Directionality is measured upward and is defined as: (Y coordinate of the end of the path minus Y coordinate of the beginning) divided by total path length. This gives 1.0 for an object moving directly upward. The roundness of the cell is a measure (in percent) of how efficiently a given amount of perimeter encloses area. A circle has the largest area for any given perimeter and has a roundness parameter of 100%. A straight line encloses no area and has a roundness parameter of 0%. We show the quantitatively measured chemotaxis behavior as described by the selected chemotaxis parameters ( Figure 2C ). It is a great technical advance to apply fluorescently labeled and controllable chemoattractant stimulation to an experimental system. Historically, we have applied either homogeneous (also called uniform) stimulation or gradient stimulation to observe cell response and behaviors. However, "blind" stimulation not only provides no spatiotemporal information on how the stimulus reaches the cells, but also casts doubt on any "abnormal" observations of cell response to stimulation, simply because we do not see the stimulus. We have previously shown that fluorescent dye (Alexa594) can be applied with chemoattractant to establish a linear relationship between chemoattractant concentration and monitored fluorescent dye intensity 15 . With an acquisition configuration of green fluorescent protein (GFP), a red emission of fluorescent dye (Alexa594), and transmitted light, we are able to monitor the adhering cells, the application of the stimulus, and the cell response to the stimulus ( Figure 3A) . Protein kinase D is a family of serine/threonine kinases that play essential roles in directed cell migration 9, 17 . In response to uniformly applied fMLP (red) stimulation, HL60 cells mediate a robust membrane translocation of GFP-tagged protein kinase D1 (green) ( Figure 3B and Movie 2) . In an fMLP gradient (red) (Figure 4A ), HL60 cells actively recruit PKD1 to the leading edge ( Figure 4B and Movie 3) . A close comparison of the subcellular localization of GFP in the protrusion of the leading edge indicates that PKD1 localizes at the rear of the leading edge ( Figure 4C) . 
Discussion
In the present study, we show two examples of chemotaxis assays: first, simultaneous monitoring of multiple chemotaxis assays by the cell mobility analysis device; and second, visualization of the chemoattractant gradient and the spatiotemporal dynamics of signaling events in the same cells in real time.
Cell mobility analysis device for multiple simultaneous chemotaxis assays
In the present study, we introduced a detailed protocol to perform multiple simultaneous chemotaxis assays using a cell mobility analysis device. This device allows user to observe cellular chemotaxis behavior with a 10X objective lens in conventional bright-field observation. Because of the diffusion-dominant characteristics of the fluid flow, the cell mobility analysis device generates highly predictable, stable gradients and allows up to six chemotaxis assays to be carried out simultaneously. The critical steps of the protocol are to obtain reliable gradients and to align the cells on the terrace line. The user should strictly follow the manufacturer's instructions for holder assembly and injection of chemoattractants and cells. Detailed instructions are also available online. Compared to alternative chemotaxis methods [11] [12] [13] 15 , this device significantly improves the reliability and efficiency of chemotaxis assays. Four sizes of cell mobility analysis device chip in sizes of 4, 5, 6, and 8 μm are available to accommodate different types and sizes of cells. We found that a 4 or 5 μm cell mobility analysis device chip is suitable for the HL60 and D.
. Another limitation is that fluorescent observation is not possible with the current device. A future direction is to monitor fluorescent imaging with higher magnification. This is possible with the improved cell mobility analysis device, which is equipped with fluorescent detection and a 100X objective lens. In addition, the number of simultaneous assays is also increased to 12. All these improvements facilitate the enhanced throughput of chemotaxis assays and the observation of subcellular dynamics in migrating cells.
High transfection efficiency of HL60 cells to express fluorescent protein-tagged protein HL60 cells are an actively dividing leukemia cell line and grow in suspension. As previously reported [18] [19] [20] , HL60 cells are resistant to gene transfer. Both lipid and electroporation gene transfer have been tested, and higher transfection efficiency was obtained with electroporation, as described in detail in section 4. Obtaining high viability after electroporation is critical for obtaining high transfection efficiency because of the severe damage that results from electroporation. Subsequently, thorough and gentle cell handling are required, especially after electroporation. All media have to be pre-warmed and gently added to the cells in any steps after electroporation. It is also critical to minimize the exposure time of cells to the electroporation reagent. To avoid cell death, after electroporation, RPMI 1640 electroporation recovery medium must be added to the cells immediately. We found that 20% FBS in the recovery medium gives a much higher cell recovery rate than 10% FBS. After electroporation, incubation in RPMI 1640 electroporation recovery medium for 30 min is critical for greater viability and transfection efficiency. To further increase transfection efficiency, we also used 4 μg plasmid DNA per transfection, which is almost the twice amount of plasmid recommended by the manufacturer.
There are two major limitations on electroporation transfection: the transiency of the protein expression and the cell number limit (2 x 10 6 cells per transfection). In undifferentiated cells, expression is detectable only during the first couple of cell divisions, since the vector plasmid is diluted by half after each cell division. For The differentiated HL60 cells survive no more than 48 hr. As a result, any experiment requires fresh transfections 6 hr prior to the experiment. The cell number for one electroporation merely meets the minimum requirement for any biochemical assays. For the purpose of repetitive use or large quantity, it is strongly recommended that an undifferentiated HL60 cell line be established that stably expresses the protein of interest which has been tagged with a fluorescent protein by a viral vector, if a viral vector is available or can be constructed.
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